Merck & Co., Inc. has a long-standing presence in the pharmaceutical industry. A significant milestone in the company's evolution was the Merck/Schering-Plough merger, which expanded its research capabilities and product reach. Today, the company operates from its global headquarters in Whitehouse Station, New Jersey, continuing a tradition of scientific innovation.

The foundation of modern healthcare rests on a commitment to rigorous research and scientific discovery. Across therapeutic areas, teams work to understand complex biological mechanisms and translate that knowledge into practical solutions. This process requires sustained investment, collaboration across disciplines, and a willingness to explore uncharted territory in pursuit of meaningful advances for patients and communities worldwide.

Vaccines represent one of the most impactful public health tools ever developed, offering protection against a range of infectious diseases that once caused widespread illness. Ongoing research continues to expand the scope of vaccine-preventable conditions, with scientists exploring new platforms and delivery methods. The goal remains consistent: to stimulate the immune system effectively and safely, reducing the burden of disease across populations of all ages.

Prescription medicines address a broad spectrum of health conditions, from chronic metabolic disorders to acute infections and complex cancers. Developing these therapies involves years of laboratory investigation, preclinical testing, and carefully monitored clinical trials. Each step is designed to evaluate safety and efficacy, ensuring that new treatment options meet the high standards expected by healthcare professionals and the patients they serve.

Cardiovascular disease continues to be a leading cause of mortality globally, driving ongoing research into innovative approaches for prevention and management. Scientific efforts focus on understanding the underlying mechanisms of heart disease, including lipid metabolism, inflammatory pathways, and vascular biology. These insights inform the development of therapies aimed at reducing risk and improving long-term outcomes for individuals living with cardiovascular conditions.

Oncology research has transformed significantly in recent decades, shifting from broad-acting treatments toward more targeted and personalized strategies. Scientists now investigate the genetic and molecular profiles of tumors to identify vulnerabilities that can be exploited therapeutically. This evolving understanding opens doors to new classes of medicines designed to intervene with greater precision and potentially fewer side effects than traditional chemotherapy approaches.

Consumer health products play an important role in everyday wellness, offering accessible options for managing common ailments and supporting general health. These over-the-counter solutions address needs ranging from pain relief and allergy management to nutritional supplementation. While distinct from prescription therapies, consumer products are developed with the same attention to quality and safety, helping individuals take an active role in their own health.

Animal health is an integral component of the broader healthcare landscape, recognizing the connections between human well-being, veterinary care, and environmental factors. Livestock health supports food security and agricultural economies, while companion animal medicine enhances the quality of life for pets and their owners. Research in this field spans vaccines, parasiticides, and treatments for chronic conditions affecting animals large and small.

The history of pharmaceutical development is marked by steady progress, built upon generations of scientific inquiry and evolving regulatory frameworks. Long-standing institutions have contributed to major public health milestones, from early vaccine programs to the introduction of novel drug classes. This heritage informs current practices while underscoring the importance of adaptability in the face of emerging health challenges and shifting global needs.

Healthcare professionals rely on accurate, up-to-date prescribing information to make informed decisions about patient care. Detailed product documentation, including indications, contraindications, dosing guidelines, and safety data, supports the responsible use of medicines. Access to this information through appropriate channels ensures that therapeutic choices are grounded in the best available evidence and aligned with regulatory standards.

Merck's vaccine portfolio addresses a range of infectious diseases. The company invests in research and manufacturing to support immunization programs globally.

Prescription medicines from Merck span cardiovascular, diabetes, oncology, bone, respiratory, immunology, dermatology, neurosciences, and ophthalmology. Each therapeutic area is supported by dedicated research and medical affairs teams.

Merck's consumer health offerings provide everyday wellness solutions. These products are developed with the same commitment to quality that defines the company's prescription and vaccine lines.

Through its animal health division, Merck delivers veterinary pharmaceuticals and biologicals. The portfolio supports livestock, poultry, and companion animal care.